Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en‐bloc transurethral resection
Histopathology · 2024
DOI: 10.1111/his.15177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Takafumi Yanagisawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Aims
We aimed to assess the oncological impact of micrometric extent of invasion in patients with pT1 bladder cancer (BCa) who underwent en‐bloc resection for bladder tumour (ERBT). Methods and results We retrospectively analysed the records and specimens of 106 pT1 high‐grade BCa patients who underwent ERBT. The extent of invasion, such as depth from basal membrane, number of invasive foci, maximum width of invasive focus, muscularis mucosae invasion and infiltration pattern (pattern A: solid sheet‐like, nodular or nested growth, pattern B: trabecular, small cluster or single‐cell pattern) were evaluated by a single genitourinary pathologist. The end‐points were recurrence‐free (RFS) and progression‐free survival (PFS). Within a median follow‐up of 23 months, overall, 36 patients experienced recurrence and 13 patients experienced disease progression. The 2‐year PFS differed significantly depending on depth from basal membrane (< 1.3 mm: 94.8% versus ≧ 1.3 mm: 65.2%, P = 0.005), maximum width of invasive focus (< 4 mm: 91.7% versus ≧ 4 mm: 62.3%, P < 0.001), muscularis mucosae (MM) invasion (above MM = 96.1% versus into or beyond MM = 64.8%, P = 0.002) and infiltration pattern (pattern A: 100% versus pattern B: 83.3%, P = 0.037). In a multivariable analysis, MM invasion [hazard ratio (HR) = 4.54, 95% confidence interval (CI) = 1.25–16.5] and maximum width of invasive focus ≧ 4 mm (HR = 4.79, 95% CI = 1.25–16.5) were independent prognostic factors of progression.
Conclusions
En‐bloc resection facilitates the evaluation of pathologic variables that might be useful in predicting disease recurrence and progression. In particular, not only the MM invasion but also the maximum width of invasion focus, reflecting the invasive volume, appear to be reliable prognosticators for disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
- Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
- Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
- Department of Urology, National Hospital Organization Ureshino Medical Center, Saga, Japan.
- Department of Urology, Saitama Medical Center, Saitama, Japan.
- Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
ORCID-Profile: Takafumi Yanagisawa
Zitieren
APA
Yanagisawa, T., Sato, S., Hayashida, Y., Okada, Y., Matsukawa, A., Iwatani, K., Shimoda, M., Takahashi, H., Kimura, T., Shariat, S. F., & Miki, J. (2024). Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en‐bloc transurethral resection. Histopathology. https://doi.org/10.1111/his.15177
Vancouver
Yanagisawa T, Sato S, Hayashida Y, Okada Y, Matsukawa A, Iwatani K, et al. Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en‐bloc transurethral resection. Histopathology. 2024. doi:10.1111/his.15177
BibTeX
@article{Yanagisawa2024,
author = {Yanagisawa, Takafumi and Sato, Shun and Hayashida, Yasushi and Okada, Yohei and Matsukawa, Akihiro and Iwatani, Kosuke and Shimoda, Masayuki and Takahashi, Hiroyuki and Kimura, Takahiro and Shariat, Shahrokh F and Miki, Jun},
title = {Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en‐bloc transurethral resection},
journal = {Histopathology},
year = {2024},
doi = {10.1111/his.15177}
}
EUVIMED